Articles

High Pharma margins increasing the squeeze on health systems

22/02/2019

Read the article here which focusses on the cost of cancer treatment versus their manufacturing costs.

Author:

Graham Foxon, PhD, MBA
About the Author

Article Tags

Oncology Pricing

Share this article

Related articles

Articles
09.09.2026
Choosing payer pricing research? Start with the qu...

Different budget pressures create different payer pricing challenges  Healthcare budget pressur...

Read more
Articles
10.08.2026
The Hidden Risk in Pharma Pricing: When Poor Gover...

Pricing strategies rarely fail because of one decision. More often, price potential is gradually ero...

Read more

Stay in the know, subscribe to our newsletter

Be the first to receive exclusive content on the latest from the pharmaceutical and market access sector.

Talk to an expert

Remap Consulting have significant experience working with pharmaceutical and biotech companies in helping them navigate global market access.​

Get in touch